The Indonesian government has taken various ways to prevent the spread of the Corona Virus. One of them is to carry out COVID-19 vaccination activities, which have been intensified since the beginning of 2021. PT Kimia Farma Tbk seeks to assist the government in accelerating the formation of herd immunity or group immunity against the COVID-19 Virus. One of them is by holding Vaccination Gotong Royong or VGR activities. This Gotong Royong Vaccination activity uses the Sinopharm vaccine type. This vaccine is of course different from the government vaccine, the Sinopharm type VGR vaccination targets people aged 18 years who have not received the vaccine at all.
Gotong Royong vaccination activities were also carried out at several universities, one of which was Palangkaraya University. This activity was carried out by health workers from Kimia Farma and assisted by KSE students of Palangkaraya University. Vaccination at Palangkaraya University was carried out twice, namely: dose 1 was carried out on Saturday, 27 November 2021, 08.00 - 14.00 WIB at the Arts Sports Building (GOR), Palangka Raya University and dose 2 was carried out on Saturday, 18 December 2021 at the Multipurpose Room of the Faculty of Medicine, Palangkaraya University. In dose 2 of the vaccine activity, 214 people were injected. During the dose 2 vaccination activity, the dose 1 injection was also reopened for the community, and 21 people were injected. Then, for people who have not injected dose 2 during the activity are directed to vaccinate at the Kimia Farma Palangkararaya Clinical Laboratory.
Vaccination activities went smoothly and without any obstacles. People who came for the vaccine followed the flow regularly, from registration to observation. In the implementation of the vaccine dose 2, there were also no KIPI (Post-Immunisation Adverse Events), where the community was allowed to wait first for 15 minutes and then allowed to go home.
It is hoped that from this activity, the community can receive a complete dose of vaccine so as to help accelerate the formation of herd immunity.
